Tower Research Capital LLC TRC Has $16.29 Million Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Tower Research Capital LLC TRC boosted its holdings in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 208.0% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 201,060 shares of the biopharmaceutical company’s stock after acquiring an additional 135,782 shares during the quarter. Tower […]

Related Keywords

United States ,Merdad Parsey ,Complera Eviplera ,Gilead Sciences Company Profile ,Gilead Sciences Inc ,Wells Fargo Company ,Gilead Sciences Announces Dividend ,News Ratings For Gilead Sciences Daily ,Tower Research Capital ,Barclays ,Nasdaq ,Quarter For Gilead Sciences ,Altfest Lj Co ,Wetzel Investment Advisors Inc ,Charles Schwab Investment Management Inc ,Gilead Sciences Price Performance ,Hermes Inc ,Maxim Group ,Gilead Sciences ,Free Report ,Research Capital ,Schwab Investment Management ,Investment Advisors ,Get Free Report ,Visit Holdingschannel ,Gilead Sciences Daily ,